Assessment of clinician awareness of nonadherence using a new structured rating scale

Journal of Psychiatric Practice

Volumn 16, Issue 3, 2010, Pages 164-169

  Clayton, Carol D ^a   Veach, Jeffrey ^a   MacFadden, Wayne ^b   Haskins, John ^b   Docherty, John P ^c   Lindenmayer, Jean Pierre ^d  

^a Care Management Technologies Inc   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adherence; Medication Adherence Assessment Tool (MAAT); Medication possession ratio (MPR); Rating scale; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ACCURACY; ARTICLE; AWARENESS; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HUMAN; INSTRUMENT VALIDATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL EXPERT; MEDICATION ADHERENCE ASSESSMENT TOOL; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRESCRIPTION; PROGRAM DEVELOPMENT; RATING SCALE; RELIABILITY; SCHIZOPHRENIA; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME; UNITED STATES;

ANTIPSYCHOTIC AGENTS; ATTITUDE OF HEALTH PERSONNEL; AWARENESS; HUMANS; MEDICATION ADHERENCE; PROGNOSIS; PSYCHOMETRICS; QUESTIONNAIRES; SCHIZOPHRENIA; TREATMENT OUTCOME; UNITED STATES;

EID: 77952845052     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pra.0000375712.85454.c6     Document Type: Article

References (23)

1. Nosé M, Barbui C, Tansella M. How often do patients with psychosis fail to adhere to treatment programmes? A systematic review. Psychol Med 2003;33:1149-1160
2. Vauth R, Löschmann C, Rüsch N, et al. Understanding adherence to neuroleptic treatment in schizophrenia. Psychiatry Res 2004;126:43-49
3. Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353:1209-1223
4. Docherty JP, Grogg A, Kozma C, et al. Antipsychotic maintenance in schizophrenia: Partial compliance and clinical outcome. Presented at: 41st Annual Meeting of the American College of Neuropsychopharmacology; December 8-12, 2002; San Juan, Puerto Rico.
5. Valenstein M, Copeland LA, Blow FC, et al. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med Care 2002;40:630-639
6. Gilmer TP, Dolder CR, Lacro JP, et al. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry 2004;161:692-699
7. Byerly M, Fisher R, Whatley K, et al. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Res 2005;133:129-133
8. Byerly MJ, Thompson A, Carmody T, et al. Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatr Serv 2007;58:844-847
9. Velligan DI, Wang M, Diamond P, et al. Relationships among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatr Serv 2007;58: 1187-1192
10. Baldessarini RJ, Perry R, Pike J. Factors associated with treatment nonadherence among US bipolar disorder patients. Hum Psychopharmacol 2008;23:95-105.
11. Hamilton RA, Briceland LL. Use of prescription-refill records to assess patient compliance. Am J Hosp Pharm 1992;49:1691-1696
12. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: Methods, validity, and applications. J Clin Epidemiol 1997;50:105-106
13. Dezii CM. Persistence with drug therapy: A practical approach using administrative claims data. Manag Care 2001;10:43-45
14. Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care 2005;11:449-457
15. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-497
16. Van Putten T, Crumpton E, Yale C. Drug refusal in schizophrenia and the wish to be crazy. Arch Gen Psychiatry 1976;33:1443-1446
17. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: Empirical and clinical findings. Schizophr Bull 1997;23:637-651
18. Kikkert MJ, Barbui C, Koeter MW, et al. Assessment of medication adherence in patients with schizophrenia: The Achilles heel of adherence research. J Nerv Ment Dis 2008;196:274-281
19. Hudson TJ, Owen RR, Thrush CR, et al. Guideline implementation and patient-tailoring strategies to improve medication adherence for schizophrenia. J Clin Psychiatry 2008;69:74-80.
20. Lawrence DB, Allison W, Chen JC, et al. Improving medication adherence with a targeted, technology-driven disease management intervention. Dis Manag 2008;11: 141-144
21. Velligan DI;Weiden PJ; Sajatovic M; et al. The expert consensus guideline series: Adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry 2009;70(Suppl 4).
22. Uzenoff SR, Perkins DO, Hamer RM, et al. A preliminary trial of adherence-coping-education (ACE) therapy for early psychosis. J Nerv Ment Dis 2008;196:572-575
23. Olfson M, Mechanic D, Hansell S, et al. Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatr Serv 2000;51: 216-222